by [email protected] | Nov 27, 2023 | Gastrointestinal, immunology, Publication
ABSTRACT Background: There is limited real-world evidence on treatment patterns of patients with Crohn’s disease (CD) initiating biologics with an extensive follow-up period. This study describes persistence and dose titration among CD patients with 3 years of...
by [email protected] | Nov 4, 2023 | Infectious Disease, Presentations
Thank you for your interest! Click here to view presentation Click here to view more of our presentations.
by [email protected] | May 31, 2023 | Cancer (blood), Cancer (solid tumor), Publication
ABSTRACT Introduction: Chemotherapy-induced nausea and vomiting (CINV) is a recognized adverse outcome among patients with cancer. This retrospective study aimed to quantify the treatment outcomes, resource utilization, and costs associated with antiemetic use to...
by [email protected] | May 11, 2023 | Dermatological, Publication
Thank you for your interest! Click here for full text. Click here to view more of our publications.
by [email protected] | May 5, 2023 | Hematology, Publication
Abstract Background: This study retrospectively compared annualized billed bleed rates (ABRb) in people with hemophilia A (PwHA) without inhibitors who switched from factor VIII (FVIII) prophylaxis to emicizumab. Research design and methods: A real-world comparison...
by [email protected] | Mar 14, 2023 | Infectious Disease, Publication
Abstract Objectives The only available oral pre-exposure prophylaxis (PrEP) regimens approved in the United States to prevent HIV infection during the period covered by this study were emtricitabine/tenofovir alafenamide (F/TAF) and emtricitabine/tenofovir...
